Diffuse large B cell lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Diffuse large B cell lymphoma}} | {{Diffuse large B cell lymphoma}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency. | The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency. |
Revision as of 17:34, 25 August 2015
Diffuse large B cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Diffuse large B cell lymphoma risk factors On the Web |
American Roentgen Ray Society Images of Diffuse large B cell lymphoma risk factors |
Directions to Hospitals Treating Diffuse large B cell lymphoma |
Risk calculators and risk factors for Diffuse large B cell lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency.
Risk factors
- An underlying immunodeficiency is a significant risk factor.